Biogen

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel... Wikipedia

• Formerly called:  Biogen Idec Inc. (2003–2015)
• Type:  Public
• Traded as:  NASDAQ: BIIB, S&P 500 component
• Industry:  Biotechnology
• Founded:  1978
• Founders:  Kenneth Murray, Phillip Allen Sharp, Walter Gilbert, Heinz Schaller, Charles Weissmann
• Key people:  Caroline Dorsa (chairman), Chris Viehbacher (CEO)
• Products:  Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza
• Revenue:  US$9.676 billion (2024)
• Operating income:  US$1.906 billion (2024)
• Total assets:  US$28.05 billion (2024)
• Total equity:  US$16.72 billion (2024)
• Number of employees:  7,605 (2024)
• Website:  biogen.com
• Data source:  DuckDuckGo